| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| 09/30/2018 |
Director
Trans History: 34
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 329 | $44.99 | 2,331 |
| 09/30/2018 |
Director
Trans History: 48
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 347 | $44.99 | 10,426 |
| 09/30/2018 |
Director
Trans History: 88
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 329 | $44.99 | 26,783 |
| 09/30/2018 |
Director
Trans History: 177
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 329 | $44.99 | 38,811 |
| 09/30/2018 |
Director
Trans History: 29
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 329 | $44.99 | 8,355 |
| 09/30/2018 |
Director
Trans History: 127
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 503 | $44.99 | 53,863 |
| 09/30/2018 |
Director
Trans History: 207
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 566 | $44.99 | 37,120 |
| 09/30/2018 |
Director
Trans History: 145
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 373 | $44.99 | 51,696 |
| 09/30/2018 |
Director
Trans History: 96
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 382 | $44.99 | 28,261 |
| 09/28/2018 |
Chief Risk Officer
Trans History: 120
|
Chief Risk Officer | Form 4/A | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7 | $40.37 | 15,561 |
- * Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.